Your browser doesn't support javascript.
loading
Comprehensive Analysis of Gene Expression Profiles Identifies a P4HA1-Related Gene Panel as a Prognostic Model in Colorectal Cancer Patients.
Chen, Zhangxing; Chen, Meiyan; Xue, Zengyan; Zhu, Xiaosan.
Afiliação
  • Chen Z; Department of Gastroenterology, Chenggong Hospital, Xiamen University, Xiamen, China.
  • Chen M; Department of Gastroenterology, Chenggong Hospital, Xiamen University, Xiamen, China.
  • Xue Z; Department of Gastroenterology, Chenggong Hospital, Xiamen University, Xiamen, China.
  • Zhu X; Department of Gastroenterology, Chenggong Hospital, Xiamen University, Xiamen, China.
Cancer Biother Radiopharm ; 36(8): 693-704, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34520234
ABSTRACT

Objective:

Colorectal cancer (CRC) is the leading cause of mortality worldwide. Growing evidence suggests that the current pathological staging system is inadequate for efficient and accurate prognosis. In this study, we aim to build a prognosis model to predict the survival outcome of CRC patients by using gene expression profiles from The Cancer Genome Atlas (TCGA). Materials and

Methods:

Univariate and multivariate Cox regression analysis were used to assess the relationship between clinical factors and P4HA1 expression regarding the prognosis of patients with colon adenocarcinoma (COAD). The least absolute shrinkage and selection operator (LASSO) Cox regression model was used to select prognostic differential expression genes (DEGs) for the construction of prognostic risk score model. Kaplan-Meier and receiver operating characteristic (ROC) survival analysis were used to assess the performance of the model on both TCGA cohort and an independent dataset GSE39582.

Results:

Overexpression of P4HA1 was confirmed to be associated with poor clinical outcome of colon cancer patients in both TCGA and GSE39582 cohorts. Using the TCGA cohort, we identified 1528 DEGs related to elevated P4HA1 expression, and we established a 11-gene panel to construct the prognostic risk score model by LASSO Cox regression analysis based on their expression profiles. The 11-gene signature was further validated in the independent dataset GSE39582. Time-dependent ROC curves indicated good performance of our model in predicting 1, 2, and 3-years overall survival in COAD patients. Additionally, gene set enrichment analysis indicated that the 11-gene signature was related to pathways involved in tumor progression.

Conclusions:

Together, we have established a 11-gene signature significantly associated with prognosis in COAD patients, which could serve as a promising tool for clinical application in the future.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Neoplasias do Colo / Pró-Colágeno-Prolina Dioxigenase / Transcriptoma Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Biother Radiopharm Assunto da revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Neoplasias do Colo / Pró-Colágeno-Prolina Dioxigenase / Transcriptoma Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Biother Radiopharm Assunto da revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China